The 2015 EMPA-REG clinical trial reported that SGLT2 inhibitor treatment reduced cardiovascular deaths by 38%
Agree
Disagree
Overview
Debates
Related claims
Topics
B
b5a31f81
Topic
Clinical trials
232
claims
·
240
news stories
0
Opening sign-in…